NCT03960008 Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant Status TERMINATED Phase PHASE3
NCT03958669 Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC Status TERMINATED Phase N/A
NCT03950102 SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist Status UNKNOWN Phase NA
NCT03945799 A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence Status TERMINATED Phase PHASE1/PHASE2
NCT03937830 Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03916627 Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03914352 A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection Status UNKNOWN Phase NA
NCT03908840 Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT03908255 Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE2
NCT03899428 Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC Status RECRUITING Phase PHASE2
NCT03899415 TCR-Redirected T Cells Therapy in Patient With HBV Related HCC Status UNKNOWN Phase PHASE1
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Status UNKNOWN Phase N/A
NCT03895359 Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma Status RECRUITING Phase PHASE3
NCT03889093 Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System Status TERMINATED Phase NA
NCT03888859 ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma Status COMPLETED Phase EARLY_PHASE1
NCT03880721 By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation Status UNKNOWN Phase N/A